Spelling suggestions: "subject:"peptidomimics"" "subject:"peptidomimic""
1 |
Combinatorial design and synthesis of peptidomimics and small molecules for protein-protein interactionsPark, Chihyo 25 April 2007 (has links)
The solid phase combinatorial method is an excellent tool for the modulation of
protein-protein interactions through focused library generations. Nucleophilic aromatic
substitution reactions with an iodinated template on solid phase has opened a door for
easy and pure libraries of 13-22 membered medium and macrocyclic peptidomimetics.
These peptide mimics showed promising activities for tyrosine kinase receptors.
Iodine functionality can then be used to modify the products, on the resin, via
Sonogashira and Suzuki couplings and presumably through other organometallic
catalysis. The coupled products can have conformational biases that differ from the
iodinated macrocycles. These coupling reactions also provide a means to introduce
additional pharmacophores and to adjust the solubilities of the products.
The fluorinated template also gave libraries of cyclic peptidomimetics on solid phase
in good yields and purities. These libraries have improved water solubility over the
iodinated libraries. The 3-fluorinated template yielded better results than the 5-
fluorinated template. Some compounds showed biological activities in cell survival
assays providing strong support of our approach to mimic external ò-turn sequences in
target proteins.
Intrasite dimerization with 1,5-hexadiyne gave a homodimer as a byproduct. Solidphase
synthesis of bivalent turn mimics with fluorescent tags has been demonstrated.
The key feature of this synthetic route is that homo- and hetero-dimers can be formed
chemoselectively from unprotected monomeric precursors. The dimerization reaction is
very mild and versatile, as only potassium carbonate is required to affect the coupling.
Solution phase library synthesis of small molecule mimics is presented. Some
monomers of full sequence mimics have been prepared to afford dimer generations. Theses monomers were combined with linker handles to afford diverse length of dimers.
Final combination of monomers to make bivalent compounds is in progress.
|
2 |
Design and Synthesis of Peptidomimics Constrained in Helical and Sheet Conformations using a Novel Covalent Surrogate for the Peptide Main Chain Hydrogen BondNallapati, Lakshmi Aparna January 2015 (has links) (PDF)
This thesis entitled “Design and Synthesis of Peptidomimics Constrained in Helical and Sheet Conformations Using a Novel Covalent Surrogate for the Peptide Main Chain Hydrogen Bond” is divided into six chapters.
Chapter 1: Introduction to Ordered Conformations of Peptides and Strategies for Constraining Short Peptides in Ordered Conformations.
The first chapter describes the different types of protein secondary structures and introduces the various prominent strategies developed thus far to constrain short peptides in ordered secondary structure-like conformations, with specific emphasis on helical and parallel β-sheet folds.
Chapter 2: Design of Structure and General Methodology for the synthesis of Novel H-Bond Surrogate Constrained Cyclic α-Helical Mimics
Here we develop the first design of the propyl linker as a covalent surrogate for the peptide H-bond. The first synthetic methodology is described for the synthesis of constraining shortest peptide sequences (tripeptides) in α-helix-like conformations. The Macrolactamization strategy proved to work best as the final step for cyclization. All residues of the turn are completely retained in the constrained sequence, unlike any other earlier method. More importantly, there are no metal involved as catalysts in any of the synthetic transformations, hence removing the problem of metal-bound cyclic structures – which have otherwise rendered these structures non-usable as drug leads in the earlier models. Gly-rich peptides have been constrained as extreme cases of highest chain entropy and least helix propensity. Both secondary and tertiary amide containing peptides have been synthesized using this protocol. Note that the macrolactamization was found to be better than the Fukuyama-Mitsunobu N-alkylation protocol for the final cyclization step.
Chapter 3: Synthesis of C-terminal Extended HBS-Constrained Helical Turn Mimics – Validation of the Versatility of Current synthetic protocol
The developed cyclization protocol is extended towards the synthesis of C-terminal
extended α-helical turn mimics using a solution phase peptide synthesis procedure. Peptides which extend belong the helical turn by a high entropy Gly-residue at the C-terminal are synthesized. The versatility of the synthetic methodology to accommodate sterically constrained amino acid residues – in the form of phenylalanine residue – at any of the positions i+1, i+2 or i+3 of the constrained helical turn is demonstrated. The synthesized are easily isolated without
need for column chromatography, in high purity and good yields – this is due to the presence of the N-terminal amino group, salts of which are easily triturated to remove all other organic impurities.
Chapter 4: Synthesis and CD conformational analyses of HBS constrained α-Helical turn mimics containing residues with improved helical propensities Alanine residue has the highest helix propensity among all other natural α-amino acid residues. Its enthalpic contribution to the helical conformation is 1 kcal/mol more than that for the Gly
residue, which has the least propensity. Incorporation of Ala residue in the Gly-rich cyclic sequences in either the middle of constrained tripeptide or as the C-terminal extended residue has been accomplished. Comparison of the CD spectra of the synthesized cyclic α-helical turn
peptides reveals that a tertiary amide linkage is essential for the propyl linker at the C-terminal amino appendage, for helicity to be observed. Helicity improves upon introduction of the first extended residue. The constrained and C-terminal extended α-helical turn mimics show consistently high helicity irrespective of the helix propensities of the component residues
showing that the covalent propyl linker surrogate for the H-bond overwhelms the natural propensities of individual amino acid residues towards enabling stabilization of the helical turn and offer far better structural organization to this cause.
Chapter 5: Synthesis of shortest HBS-constrained 310 and - helical peptide
analogues
The unique versatility of the novel covalent propyl linker surrogate for the peptide H-bond is exhibited by its ability to constrain dipeptides in 310-helix like structures. This is the first and the
only HBS model that can achieve this synthetic target as the synthetic protocol allows the conservation of both the residues as is in the constrained helical turn. Similarly, the trapping of a pentapeptide in a C-terminal extended rare and unstable -helix like cyclic structure using the
current HBS linker is achieved. Considering the high entropic cost for cyclizing such a long 16-membered chain into a constrained structure, this again exhibits the versatility of the currently developed HBS design and the currently developed synthetic methodology.
Chapter 6: First design and synthesis of novel H-bond surrogate constrained
parallel β-sheet mimics H-bonding interactions stabilize another prevalently observed secondary structure, other than
helical structures, namely the -sheets. The parallel -sheets that almost qualify for super secondary structures due to the high contact orders in them are thought to mimic in models, unlike the easier antiparallel -sheets. Here we replace the inter-strand peptide H-bond between parallel -strands to create excised templates as parallel -sheet nucleators. The propyl linker acts as a dynamic linker in these models and the two amino groups are protected with bulky
sulphonamides, in order to provide Thorpe-Ingold effect to the peptide chain. The protocol for synthesizing these models has been described and the different analogues that are synthesized thus have been described. This is the first instance of synthesis of parallel -sheet mimics using
the covalent surrogates for the peptide H-bond.
|
Page generated in 0.0316 seconds